Predictors of elevations in fasting lipid levels in adults with epilepsy on a modified Atkins diet.

Epilepsy is estimated to affect ∼68 million people worldwide with a median prevalence of 0.58% (0.27-1.24) in developed countries, 1.54% (0.48-4.96) in rural and 1.03% (0.28-3.77) in urban developing countries[1]. Roughly 1/3 of patients with epilepsy fail to respond to anti-seizure medication and have less than a 5% chance of s eizure freedom with successive anti-seizure medication trials despite the development of over 25 different anti-seizure medications over the last century[2,3]. For these individuals with drug-resistant epilepsy, non-pharmacologic approaches including ketogenic diet therapies (KDTs) offer needed adju nctive strategies.
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Source Type: research